AVNSAvanos Medical, Inc.
Price
+114%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, a flag to check, demanding price, growth steady, the market with it.
Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior medical device solutions that help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, we are committed to addressing some of today’s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery.
In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Avanos Medical, Inc. (AVNS) reported revenue of $182M in Q1 2026 (quarter ended Mar 31, 2026), up 8.8% from the same quarter a year earlier. That came with a gross margin of 52% and net income of $5.1M (2.8% of revenue). For the full year FY2025, revenue was $701M (+1.9% year on year) and net income −$73M. Its largest product in Q1 2026 was Enteral Feeding at $85M, 46% of the disclosed total, well ahead of Neonate Solutions at 22%.
Business segments
Mar 2026 · $182.2MThe company’s own SEC segment disclosure.
- Enteral Feeding$84.6M46%
- Neonate Solutions$39.4M22%
- Radiofrequency Ablation$34.5M19%
- Surgical Pain and Recovery$21.8M12%
- Corporate Other$1.9M1%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
The closest names by size in the same industry